Low-dose dopamine does not prevent acute renal failure in patients with septic shock and oliguria. NORASEPT II Study Investigators

Am J Med. 1999 Oct;107(4):387-90. doi: 10.1016/s0002-9343(99)00246-6.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study

MeSH terms

  • Acute Kidney Injury / etiology*
  • Acute Kidney Injury / mortality
  • Acute Kidney Injury / prevention & control*
  • Adult
  • Analysis of Variance
  • Cardiotonic Agents / administration & dosage
  • Cardiotonic Agents / therapeutic use*
  • Chi-Square Distribution
  • Dopamine / administration & dosage
  • Dopamine / therapeutic use*
  • Female
  • Humans
  • Male
  • Oliguria / complications*
  • Randomized Controlled Trials as Topic
  • Shock, Septic / complications*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Cardiotonic Agents
  • Dopamine